Jasper Therapeutics Appoints Regulatory, Clinical Executives For Pipeline Development; Stock Up
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Wed, 16 September 2026
What it is about
Lisa PittShiguang LiuKira PharmaceuticalsGlaxosmithklineClinical DevelopmentRegulatory AffairsRegulatory Affairs At Aiolos BioDrug Administration
Who published it, and when
How it spread - 1 original report
Wed, 16 September 2026
1 report- rttnews.com07:15first to report
Jasper Therapeutics, Inc. (JSPR), a clinical-stage biotechnology company focused on immune-mediated diseases, announced the appointments of Lisa Pitt as Senior Vice President, Regulatory Affairs and Shiguang Liu as Vice President, Clinical Development.